Barry R. DeYoung

Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.

G. T. Budd, E. Hawk, G. Kelloff, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.

G. Piazza, M. Nitert, J. Church, 1999, Advances in experimental medicine and biology.